Table 14.
Change from Baseline to 1-Year Visit* | Sham N = 233 | Ranibizumab N = 303 | Triamcinolone N = 150 |
---|---|---|---|
Baseline severity: Moderately severe NPDR or better, No. (%) | N = 150 | N = 182 | N = 80 |
Improved by 2 or more levels | 6 (4%) | 46 (25%) | 20 (25%) |
Worsened by 2 or more levels | 11 (7%) | 5 (3%) | 2 (3%) |
P value for comparison with Sham | P = 0.08 | P = 0.17 | |
Baseline severity: Severe NPDR or worse, No. (%) | N = 83 | N = 121 | N = 70 |
Improved by 2 or more levels† | 10 (19%) | 18 (28%) | 6 (13%) |
Worsened by 2 or more levels | 7 (8%) | 1 (1%) | 2 (3%) |
P value for comparison with Sham | P = 0.03 | P = 0.17 |
NPDR = non-proliferative diabetic retinopathy
N = 685; 113 eyes had missing or ungradeable photos at 1 year
Excludes 127 eyes with baseline Level 60 (scars of full or partial PRP present; abnormalities of PDR absent)